In a few decades, gene-editing technologies could reduce the likelihood of common human diseases. Societies must use this ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...

Anges Inc. has entered into a sponsored research agreement with Stanford University School of Medicine for the development of novel cancer therapies using genome editing technology. The parties aim to ...

A team of scientists claims that the risk of common conditions like heart disease could be slashed by editing people's ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Genome editing with CRISPR-Cas is often associated with the induction of mutations. However, a team of researchers from the ...

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...

Biochemist Jennifer Doudna, a faculty scientist at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), founder of the ...

Caribou has initiated the GALLOP Phase 1 clinical trial, an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today provided updates on the successful ...

We are excited to welcome Eric to our Board of Directors,” said Brian C. Thomas, PhD, CEO and founder of Metagenomi. “His tremendous track record in the pharmaceutical industry as well as his ...

The de-extinction company led by CEO Ben Lamm has raked in $435 million in funding since its launch. He believes it has ...